跳至主要内容
临床试验/PACTR201312000661337
PACTR201312000661337已完成未知

COMPARISON OF THE THERAPEUTIC EFFICACY AND ADVERSE EFFECTS PROFILE OF TENOFOVIR/LAMIVUDINE AND ZIDOVUDINE/LAMIVUDINE -BASED FIXED DOSE REGIMENS IN THE TREATMENT OF ANTIRETROVIRAL (ART) ¿NAÏVE HIV/AIDS PATIENTS IN ZARIA, NIGERIA.

ABUTH0 个研究点目标入组 198 人开始时间: 2013年10月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
ABUTH
入组人数
198

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 70 Year(s)(—)
性别
All

入选标准

  • HIV subjects who signed a written consent and satisfy the following criteria:
  • 1. Aged ¿ 18 years
  • 2. Had never received ART in the past either for treatment, post-exposure prophylaxis or PMTCT.
  • 3. Had a baseline CD4 count of ¿350 cells/mm3 irrespective of WHO clinical staging; or WHO stage 3 or 4, irrespective of the CD4 count.
  • 4. Seronegative for both HBsAg and HCV Ab.
  • 5. Had the following baseline parameters: Hemogram ¿ 10g/dL, Platelet count ¿ 80,000/mm3, Absolute Neutrophil count ¿ 1000/mm3, Creatinine clearance ¿ 50mL/min (Cockcroft ¿Gault method), Serum Alanine transaminase level ¿ ×3 upper limit of normal.

排除标准

  • HIV positive subjects who were:
  • 1. Aged < 18 years old
  • 2. Have documented history of renal disease or have a baseline estimated creatinine clearance of < 50mL/min.
  • 3. On nephrotoxic or cytotoxic drugs
  • 4. Have documented history of liver disease or have a baseline ALT ¿ x 3 ULN
  • 5. Subjects who have symptomatic anemia or baseline Hemogram of < 10mg/dL.

研究者

发起方
ABUTH

相似试验